期刊文献+

SGLT1在肝癌组织中的表达及意义 被引量:1

Expression and significance of SGLT1 in human liver cancer
下载PDF
导出
摘要 目的:比较钠葡萄糖共转运体SGLT1在肝癌组织和癌旁组织的表达,及SGLT1与肝癌TNM分级的相关性。方法:采用SP免疫组化技术,对79例肝癌患者组织芯片进行染色,统计学分析。结果:SGLT1在肝癌中阳性率高于癌旁组织,差异具有统计学意义(P<0.001),并且SGLT1在肝癌中表达程度与肝癌TNM分期具有相关性(P<0.001)。结论:SGLT1在肝癌中表达程度与肝癌TNM分期具有相关性,提示SGLT1在肝癌的发生和发展中有意义,通过对SGLT1介导的肿瘤依赖葡萄糖能量代谢的研究,为肝癌的发展机制研究提供新的理论基础。 Objective : To detect the expression of sodium/glucose co - transporter 1 ( SGLT1 ) in liver cancer tis- sue and paired adjacent normal tissue, and the relation with the TNM classification of liver cancer. Methods:The ex- pression of SGLT1 in liver cancer tissue and adjacent normal tissue were assayed by immunohistochemical staining. Results:The expression of SGLTI in liver cancer was higher than adjacent normal tissue. And the level of SGLT1 in liver cancer was positively correlated with tumor pathology TNM classification. Conclusion:The SGLT1 protein level is inversely correlated with TNM classfication. Targeting the actions of SGLT1 in cell glucose - dependent energy de- livery may provide an attractive strategy for diagnosis and therapeutic intervention in human hepatocellular carcinoma.
出处 《现代肿瘤医学》 CAS 2015年第3期354-356,共3页 Journal of Modern Oncology
基金 国家自然科学基金(编号:81172287)
关键词 SGLT1 肝癌 免疫组化 SGLT1 hepatocellular carcinoma immunohistochemical staining
  • 相关文献

参考文献1

二级参考文献10

  • 1Pierre-Alain Clavien,Mickael Lesurtel,Patrick MM Bossuyt,Gregory J Gores,Bernard Langer,Arnaud Perrier.Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report[J]. Lancet Oncology . 2012 (1)
  • 2Wen-Yen Huang,Yee-Min Jen,Meei-Shyuan Lee,Li-Ping Chang,Chang-Ming Chen,Kai-Hsiung Ko,Kuen-Tze Lin,Jang-Chun Lin,Hsing-Lung Chao,Chun-Shu Lin,Yu-Fu Su,Chao-Yueh Fan,Yao-Wen Chang.Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma[J]. International Journal of Radiation Oncology, Biology, Physics . 2012 (2)
  • 3European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4)
  • 4Jin‐Kyu Kang,Mi‐Sook Kim,Chul Koo Cho,Kwang Mo Yang,Hyung Jun Yoo,Jin Ho Kim,Sun Hyun Bae,Da Hoon Jung,Kum Bae Kim,,Dong Han Lee,Chul Ju Han,Jin Kim,Su Cheol Park,Young Han Kim.Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization[J].Cancer.2012(21)
  • 5Han Chong Toh,Pei‐Jer Chen,Brian I. Carr,Jennifer J. Knox,Sharlene Gill,Peter Ansell,Evelyn M. McKeegan,Barry Dowell,Michelle Pedersen,Qin Qin,Jiang Qian,Frank A. Scappaticci,Justin L. Ricker,Dawn M. Carlson,Wei Peng Yong.Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma[J].Cancer.2012(2)
  • 6Kiyoshi Hasegawa,Norihiro Kokudo,Masatoshi Makuuchi,Namiki Izumi,Takafumi Ichida,Masatoshi Kudo,Yonson Ku,Michiie Sakamoto,Osamu Nakashima,Osamu Matsui,Yutaka Matsuyama.Corrigendum to: “Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey” [J Hepatol 2013;58:724–729][J].Journal of Hepatology.2013
  • 7Cheng-Maw Ho,Po-Huang Lee,Wen-Yi Shau,Ming-Chih Ho,Yao-Ming Wu,Rey-Heng Hu.Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalities[J].Surgery.2012(5)
  • 8Riad Salem,Robert J. Lewandowski,Laura Kulik,Edward Wang,Ahsun Riaz,Robert K. Ryu,Kent T. Sato,Ramona Gupta,Paul Nikolaidis,Frank H. Miller,Vahid Yaghmai,Saad M. Ibrahim,Seanthan Senthilnathan,Talia Baker,Vanessa L. Gates,Bassel Atassi,Steven Newman,Khairuddin Memon,Richard Chen,Robert L. Vogelzang,Albert A. Nemcek,Scott A. Resnick,Howard B. Chrisman,James Carr,Reed A. Omary,Michael Abecassis,Al B. Benson,Mary F. Mulcahy.Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma[J].Gastroenterology.2011(2)
  • 9David L. Andolino,Cynthia S. Johnson,Mary Maluccio,Paul Kwo,A. Joseph Tector,Jennifer Zook,Peter A.S. Johnstone,Higinia R. Cardenes.Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma[J].International Journal of Radiation Oncology Biology Physics.2011(4)
  • 10Tsutomu Tamai,Hirofumi Uto,Yoichiro Takami,Kouhei Oda,Akiko Saishoji,Masashi Hashiguchi,Kotaro Kumagai,Takeshi Kure,Seiichi Mawatari,Akihiro Moriuchi,Makoto Oketani,Akio Ido,Hirohito Tsubouchi.Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma[J].World Journal of Gastroenterology,2011,17(44):4890-4898. 被引量:7

共引文献19

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部